Skip to main content
. 2021 Jul 14;13(7):488. doi: 10.3390/toxins13070488

Table 1.

The most frequently reported reason for screening failure.

TRUDOSE Pilot TRUDOSE II
Patients screened, n 116 89
Ineligible patients that did not meet inclusion/exclusion criteria, n 77 45
Insufficient treatment time 62 20
Lack of confirmed diagnosis ≥ 2 years before the switch 11 0
Surgical procedure involving bone or muscle for disease management 4 7
Enrollment in another clinical trial 0 7
Changes in adjuvant therapy for dystonia that could affect disease severity or result in increased adverse events 0 7
Evaluable patients, n 39 44